Celiac disease, vaccines and the spleen: what the guidance says

Short answer

Published guidance raises two vaccine questions for celiac disease, and a clinician decides whether either applies:

  1. Hepatitis B vaccine: a 2015 meta-analysis reports non-protective antibody responses more often in patients than controls7, but a 2022 Mayo Clinic study says its results do not support screening and revaccination within the United States19.
  2. Spleen function and pneumococcal vaccine: the American College of Gastroenterology (ACG) suggests pneumococcal vaccination in celiac disease, on low-quality evidence48; it says the increased pneumococcal risk is believed to be due to hyposplenism, found in approximately one-third by pitted red cell counting47.

Published by Gluten Verdict · updated · 20 sources, each linked below

Reviewed by Mark Peter, Registered dietitian (RD), on

Folded pharmacy paper bag with a stapled receipt on a car seat beside a turquoise tote

Key points

  • Sources differ on the hepatitis B vaccine in celiac disease: ESPGHAN reports poor seroconversion in children9, while a 2022 Mayo Clinic study says its results do not support screening and revaccination within the United States19.
  • CDC’s Pink Book does not recommend routine postvaccination testing and does not name celiac disease among the groups it does list25, 26.
  • Reported hyposplenism figures vary by group and method: 5.1% in treated celiac disease in one study42, 20–80% in a review depending on the method62.
  • CDC’s schedule names asplenia, not celiac disease57, 59, and says it is being revised60.

Two vaccine questions, kept apart from the ingredient question

Two different things get called “celiac disease and vaccines”. One is how well vaccines work in people with celiac disease, which is what this guide covers. The other is whether a vaccine contains gluten, which is an ingredient question with its own guide.

On the first, published guidance raises two questions. The Celiac Disease Foundation singled out the hepatitis B vaccine as one notable exception to otherwise normal vaccine response1. The other question is reduced spleen function, called hyposplenism, and what it means for pneumococcal vaccination; both are covered below.

This page reports what named sources say. It is not advice for one person: whether either question applies to you or your child is a clinician’s decision.

What studies report about the hepatitis B vaccine

Gluten Intolerance Group says numerous research studies have found the hepatitis B vaccine less likely to be effective in people with celiac disease3. One pooled analysis is a 2015 systematic review and meta-analysis. It selected twelve retrospective studies (1,447 participants) and four prospective studies (184 subjects)5, and its authors report that non-protective antibody responses occurred more often in patients than in controls7.

For children, the 2022 position paper from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) says vaccine responses in children with celiac disease are identical to those of the general population, with one exception: a moderate level of evidence of poor seroconversion in response to hepatitis B vaccine9. In general, CDC’s Pink Book lists older age (40 and over), male sex, obesity, diabetes, smoking and chronic illness as independently associated with nonresponse to hepatitis B vaccine29. Celiac disease is not among the factors that chapter names69.

Hepatitis B vaccine response: what each source reports (their figures, not ours)
SourceWho was studiedWhat it reports
2015 systematic review and meta-analysisPatients with celiac disease and controls; 12 retrospective and 4 prospective studies5Rate ratios for a protective response of 0.732 in the prospective and 0.777 in the retrospective studies6; the authors say more trials are needed8
ESPGHAN 2022 position paperChildren and adolescents50% of patients with celiac disease had a poor antibody response versus 11% of controls when vaccinated in the first 6 months of life10
Mayo Clinic, 2022A US national survey (NHANES, 2009-2014) and two cohorts20Vaccination and immunity rates were similar with and without celiac disease; the authors say the results do not support screening and revaccination in the United States19
Mayo Clinic, 2023Retrospective cohort of patients first diagnosed with inflammatory bowel disease or celiac disease in Olmsted County, Minnesota21Referents had protective titers more often within 15 years of the last vaccine23, yet no new hepatitis B infection developed in any of 1258 patients over a median follow-up of 9.4 years24

The rows measure different outcomes in different groups (antibody response, immunity rates, infections), so read them side by side rather than as one answer. The meta-analysis authors name limitations in the available studies themselves8.

Does eating gluten at the time of vaccination matter?

One study of 128 children and adolescents with celiac disease and 113 age-matched controls18 looked at gluten intake. It found the response rate in one group was 50.9% and correlated with gluten intake: 25.9% in untreated patients, 44.4% on a non-strict diet and 61.4% on a strict diet15. Treated and compliant patients did not differ significantly from controls16. Thirty-seven patients with a negative result received a booster during a controlled gluten-free diet, and 36 of them seroconverted17.

The Celiac Disease Foundation’s 2015 article concluded that, from the studies it reviewed, only patients with active and untreated celiac disease seem to be at risk of not responding2. Gluten Intolerance Group is more cautious: it says the best course is to discuss the situation with a personal physician and healthcare team to decide whether re-vaccination is needed4.

That is one study’s result for one group of young people. The ESPGHAN paper says there is no current evidence that the response should be evaluated during follow-up, but that revaccination should be performed if a poor antibody response is detected12.

What guidance says about checking the antibody level

The CDC Pink Book, chapter 10, says testing for immunity after vaccination is not recommended routinely25. It lists the groups for whom testing is recommended, and celiac disease is not one of them26. It also says that anti-HBs of at least 10 mIU/mL after the primary series counts as immune28, and that a lower result after the primary series should lead to revaccination27. The chapter carries a notice that its vaccine-specific recommendations may be outdated30.

What each source says about checking hepatitis B antibody in celiac disease
SourceWhat it says
CDC Pink Book (general population)Routine postvaccination testing not recommended25; celiac disease is not among the groups named26
ACG guideline, 2023 (adults and children)No mention of hepatitis B vaccination or antibody testing31
ESPGHAN position paper, 2022 (children)Antibody levels may be measured in previously immunized patients if this is considered important in the population, with a booster if levels are inadequate11; screening has been suggested in newly diagnosed children13
Celiac Disease Foundation follow-up pageLists assessing hepatitis B, influenza and pneumococcal vaccination status at diagnosis32, and hepatitis B immunization status at the 12-month visit if previously abnormal33
Mayo Clinic studies, 2022 and 20232022: results do not support screening and revaccination in the United States19. 2023: routine testing of anti-HBs may not be indicated for fully vaccinated patients with inflammatory bowel disease or celiac disease, with more studies needed22

So the sources do not give one answer on routine testing25, 11, 19.

Hyposplenism: what it is, how it is found, how common it is reported to be

A review in Digestive Diseases says the spleen plays a vital role in filtering and immunological processes35. It calls functional hyposplenism a recognized complication of several gastroenterological disorders, including coeliac disease36, and says its mechanisms are poorly understood37. A 2024 study describes hyposplenism as an acquired impairment of spleen function, associated with reduced IgM memory B cells and increased susceptibility to serious pneumococcal infection40.

How it is found

Authors of one study tested for Howell–Jolly bodies and pitted red cells and did spleen ultrasound41; they also say that functional B cell defects, which they found common, are not detected by current clinical tests43. A review in Expert Review of Gastroenterology & Hepatology says physicians could search for signs of hyposplenism on a peripheral blood smear or abdominal ultrasound45, and adds that the best strategy to identify which patients will benefit from pneumococcal vaccination has not yet been defined46. ACG’s one-third figure below comes from pitted red cell counting47.

How common it is reported to be

Reported hyposplenism in celiac disease: the figure depends on who and how
SourceFigureScope
ACG guideline, 2023Approximately one-third of people with celiac disease47By pitted red cell counting
Review in Vaccines, 202420–80% of patients62Depends on the method each study used
Digestive Diseases reviewOnly 19% of uncomplicated adult coeliac patients in one study38Adults without complications; more common in celiac disease with complications39
Study in Vaccines, 2024Rare in treated celiac disease (5.1%)42Treated celiac disease

The review in Vaccines adds that hyposplenism is most frequent in people diagnosed with celiac disease in adulthood64, and says a gluten-free diet reverts splenic function except in those with splenic atrophy63.

Pneumococcal vaccination and celiac disease

The case for the question rests partly on infection data. A systematic review and meta-analysis found higher odds of pneumococcal infection among hospitalized celiac patients than controls (odds ratio 1.66; 95% confidence interval 1.43-1.92)54. It was based on three large databases out of 156 articles screened55. Its authors concluded that preventive pneumococcal vaccination should be considered, with special attention to people aged 15-64 who have not received the scheduled series as a child56.

ACG’s 2023 guideline suggests vaccination to prevent pneumococcal disease in patients with celiac disease, as a conditional recommendation based on low-quality evidence48. It says the specific regimen depends on age, immunization record and comorbidity, following CDC recommendations49, and that for complex scenarios a vaccination clinic or infectious disease specialist is reasonable51.

What CDC’s schedule names

CDC’s adult schedule notes list “congenital or acquired asplenia” among the underlying conditions for pneumococcal vaccination at ages 19 to 4957, and “anatomical or functional asplenia” for Hib vaccination58. Celiac disease is not named on that page59. ACG describes functional asplenia as a common clinical association in celiac disease50. Whether a given person’s spleen function counts is a clinical judgment this page cannot make.

CDC’s adult schedule landing page says its contents are being revised to reflect updated recommendations60. We do not restate doses or vaccine types here; the schedule on CDC’s site and your clinician’s copy are the reference.

Not every group frames it as a rule. A study group proposing that guidelines recommend routine pneumococcal vaccination, ideally conjugate, for all celiac patients instead of hyposplenism screening is stating its own recommendation44, and a 2024 review notes that specific recommendations on immunization practices for people with celiac disease have not been released65.

Other vaccines

A 2017 review of children concluded that the immunological response to vaccines in children with celiac disease does not differ markedly from that of the general population, except for hepatitis B virus vaccine68. A 2024 review reaches the same overall reading66, and says that for patients at risk of infections, vaccination against pneumococcus and other encapsulated bacteria should be recommended67.

ESPGHAN adds that there is currently no evidence to support routine checking of vaccine response during follow-up14. The Celiac Disease Foundation’s follow-up page lists an annual influenza vaccination34; CDC’s adult schedule recommends one dose of any influenza vaccine appropriate for age and health status annually for adults 19 and older61.

Where the evidence is thin

  • The hepatitis B meta-analysis authors themselves say additional trials are needed8.
  • The 2023 Mayo study is a retrospective cohort from one Minnesota county21, and its authors say more studies are needed in other settings and populations22.
  • ACG rates its pneumococcal recommendation as conditional, on low-quality evidence48.
  • ACG lists open questions: how effective the pneumococcal vaccine is in celiac disease and whether that differs from the general population52, and what the best regimen is53.
  • How to find who has reduced spleen function is not settled46.

Questions to bring to the visit, and who decides

These come from the sections above, not from a source’s advice to you. Pick the ones that fit.

  1. Is my (or my child’s) hepatitis B vaccination record complete, and has an antibody level ever been measured?
  2. Was the hepatitis B series given before or after the gluten-free diet began?
  3. Does my clinician follow the position that the antibody level should be measured, or the position that routine testing is not needed? Which one, and why?
  4. Is reduced spleen function a question for me, and how would it be looked for?
  5. Which pneumococcal vaccine, if any, applies given my age, record and conditions, and which version of the CDC schedule is the clinic using?
  6. Who decides, and where will the decision be written down?

The decision belongs to the treating clinician. ACG notes that a vaccination clinic or infectious disease specialist is reasonable for complex scenarios51.

Questions people ask

Do people with celiac disease need extra vaccines?

ACG suggests pneumococcal vaccination for patients with celiac disease48, while a 2024 review notes that specific recommendations on immunization practices for people with celiac disease have not been released65. A clinician decides against the current CDC schedule.

Is the hepatitis B vaccine less effective in celiac disease?

A 2015 meta-analysis reports non-protective responses more often in patients than in controls7, while a 2022 Mayo Clinic study says its results do not support screening and revaccination within the United States19, and a 2023 one says routine antibody testing may not be indicated for fully vaccinated patients with inflammatory bowel disease or celiac disease22.

Does a gluten-free diet improve a weak hepatitis B vaccine response?

In one study of children and adolescents, 36 of 37 patients with a negative result seroconverted after a booster given during a controlled gluten-free diet17.

What is hyposplenism?

An acquired impairment of spleen function, associated with reduced IgM memory B cells and increased susceptibility to serious pneumococcal infection40. Reported rates in celiac disease range widely with who was studied and the method used62.

More in Related conditions and complications

Sources